The researchers found a molecule called beta-arrestin that can cause bone to form and then discovered a way to reduce the loss of bone, while stimulating bone growth.
The research was reported in the inaugural issue of the journal Science Translational Medicine.
Read UPI’s report on a new bone-growing therapy.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
